MedPath

Investigation of the effect of metformin gel on severe chronic periodontitis

Phase 3
Conditions
Chronic periodontitis.
Chronic periodontitis
K05.3
Registration Number
IRCT20200623047900N1
Lead Sponsor
Zahedan University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
All
Target Recruitment
50
Inclusion Criteria

Conscious consent of the patient to participate in the research
The depth of the periodontal pocket is greater than or equal to 5 mm
Do not consume alcohol and any tobacco
Do not take antibiotics for three months before the visit
No history of periodontal treatment 6 months before referral
Non-consumption of systemic metformin
Lack of any systemic disease that is effective in a person's periodontal condition.
Not being pregnant or breastfeeding

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Clinical attachment loss. Timepoint: After 3 weeks, 2 months and 4 months after placing the drug deep in the Periodontal pocket. Method of measurement: Through a clinical examination.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath